Key Information For AXSM

  2. >
  3. AXSM
Ticker AXSM
Description Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Exchange NASDAQ
Industry Sector Healthcare
Last Trade Price $85.20
Previous Close $87.76
52-Week High $109.94
52-Week Low $7.63
IV Percentile 10th
IV Rank 10.92%
IV Skew Percentile 0
IV Skew Directional Sentiment Bullish
50-Day Moving Avg. $66.53
200-Day Moving Avg. $33.87
10-Day Avg. Volume 797,647
20-Day Avg. Volume 1,072,019
30-Day Avg. Volume 1,693,496
3-Month Avg. Volume 1,335,870
EPS $-1.61
Next Earnings Date Est. March 18th, 2020
Outstanding Shares 36,891,000
Float 28,635,680
Market Capitalization $3,228,300,300
Employees 29
Minimum Tick $0.0001
Minimum Tick >= $1.00 $0.01
Security Type Stock
Currency USD
Information Updated January 24th, 2020